- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neuroimaging Biomarkers for Alzheimer’s Disease ; volume:14 ; number:1 ; day:7 ; month:6 ; year:2019 ; pages:1-14 ; date:12.2019
Molecular neurodegeneration ; 14, Heft 1 (7.6.2019), 1-14, 12.2019
- Urheber
-
Márquez, Freddie
Yassa, Michael A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-019-0325-5
- URN
-
urn:nbn:de:101:1-2019102123265524975498
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Márquez, Freddie
- Yassa, Michael A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Blood biomarkers for Alzheimer’s disease
Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
Biomarkers in Alzheimer’s disease
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Exploring modulators of tau spreading in Alzheimer’s disease through multi-modal neuroimaging biomarkers
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer’s disease
Author Correction: Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer’s disease
Blood‐based biomarkers for Alzheimer's disease
Blood biomarkers for Alzheimer’s disease
Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
Biomarkers in Alzheimer’s disease
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Exploring modulators of tau spreading in Alzheimer’s disease through multi-modal neuroimaging biomarkers
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer’s disease
Author Correction: Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer’s disease
Blood‐based biomarkers for Alzheimer's disease
Blood biomarkers for Alzheimer’s disease
Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
Biomarkers in Alzheimer’s disease
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Exploring modulators of tau spreading in Alzheimer’s disease through multi-modal neuroimaging biomarkers
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer’s disease
Author Correction: Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer’s disease